Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

AmBisome approved in Korea

Aug. 8, 1997

Shionogi's beta-lactam antibiotic launched in Japan

Aug. 7, 1997

CytoGam approved for marketing in Canada

Aug. 7, 1997

AmBisome approved in Russia

Aug. 7, 1997

New cephems active against MRSA

Aug. 6, 1997

BE-44651B disclosed in patent literature by Banyu

Aug. 6, 1997

EGS oligozymes make drug-resistant bacteria sensitive

Aug. 5, 1997

New oxazolidinones from P&U

Aug. 4, 1997

Grepafloxacin receives first approval in Germany

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...